期刊文献+

脓毒症发病机制及标志物新进展 被引量:12

下载PDF
导出
摘要 脓毒症是世界范围内的致死性疾病之一,在美国,每年大约有超过650,000例脓毒症患者[1].严重脓毒症的发生率在逐年增加,死亡率仍居高不下[2],而其中30%的存活者存在长期的功能残疾或认知损害[3].在治疗方面,应用抗炎介质和抗细胞因子治疗的临床实验大都以失败告终,其中部分原因是由于缺乏对脓毒症发生发展以及脓毒症相关脏器损伤的分子机制的了解.本综述主要是关于脓毒症的发病机制方面的新进展以及生化标志物在脓毒症的早期诊断中的作用.
出处 《中日友好医院学报》 2014年第6期355-357,共3页 Journal of China-Japan Friendship Hospital
  • 相关文献

参考文献25

  • 1Martin GS,Mannino DM,Eaton S,et al.The epidemiology ofsepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348 : 1546.
  • 2Gaieski DF,Edwards JM,Kallan MJ,et al.Benchmarking the incidence and mortality of severe sepsis in the United States[J].Crit Care Med ,2013,41 : 1167-1174.
  • 3Iwashyna TJ,Ely EW,Smith DM,et al.Long-term cognitive impair-ment and functional disability among survivors of se- vere sepsis[J].JAMA ,2010,304 : 17871794.
  • 4Tabas I,Ron D.Integrating the mechanisms of apoptosis in- duced by endoplasmic reticulum stress [J].Nat Cell Biol, 2011,13 (3) : 184-190.
  • 5Seimon T,Tabas I.Mechanisms and consequences of macrophage apoptosis in atherosclerosis[.l].J Lipid Res,2009, 50 :$382-$387.
  • 6Harrois A,Huet O,Duranteau J.Alterations of mitochondrial function in sepsis and critical illness [J].Curr Opin Anaes- thesiol, 2009,22 : 143.
  • 7Haden DW,Suliman HB,Carraway MS,et al.Mitochondrial biogenesis restores oxidative metabolism during staphylococ- cus aureus sepsis[J].Am J Respir Crit Care Med,2007,176: 768.
  • 8Hotchkiss RS,Karl IE.The pathophysiology and treatment of sepsis[J].N Engl J Meal,2003,348(2) : 138-150.
  • 9Pinsky MD.Dysregulation of the immune response in severe sepsis[J].Am J Med Sci,2004,328(4) :220-229.
  • 10Tracey KJ.Physiology and immunology of the cholinergic antiinflamatiory pathway[J].Clin Invest,2007,117 (2):289- 296.

二级参考文献21

  • 1喻文亮,陆铸今,孙波.小儿、新生儿全身炎症反应综合征、脓毒症及感染性休克新定义[J].中国小儿急救医学,2006,13(1):1-4. 被引量:48
  • 2邱海波.应强化和落实严重感染的早期加强治疗策略[J].中华急诊医学杂志,2007,16(2):119-120. 被引量:22
  • 3成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:69
  • 4Vincent JL. Clinical sepsis and septic shock-definition, diagnosis and management principles[J]. Langenbecks Arch Surg,2008,393(6):817- 824.
  • 5Russel JA. The current management of septic shock[J]. Minerva Med, 2008,99(5) :431-458.
  • 6Dellinger RP, Levy MM, Cadet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med,2008,36(1):296-327.
  • 7Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis shock[ J]. N Engl J Med, 2001,345 (19) : 1368-1377.
  • 8Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock[J]. Chest, 2009,136( 1 ) : 102-109.
  • 9Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/ SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med,2003,31(4):1250-1256.
  • 10M Malbrain, T De Potter, et al. Ejection fraction (EF) corrected volumetric parameters better reflect preload and fluid responsiveness [ J ]. Critical Care,2004, 8(Suppl 1):4-7.

共引文献20

同被引文献169

引证文献12

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部